-
Exenatide, sold
under the
brand name
Byetta among others, is a
medication used to
treat type 2 diabetes. It is used
together with diet, exercise, and...
- the
exception of insulin, most GLP-1
receptor agonists (liraglutide,
exenatide, and others), and pramlintide, all
diabetes medications are administered...
-
produced three drugs:
Symlin (pramlintide acetate),
Byetta (
exenatide) and
Bydureon (
exenatide extended release). In 1987,
Amylin Pharmaceuticals was co-founded...
-
version of exendin-4
called exenatide. In 2002, Eli
Lilly entered into an
alliance with
Amylin to
further develop exenatide and
secure official approval...
-
pancreatitis including metformin, but glucagon-like peptide-1
mimetics such as
exenatide are more
strongly ****ociated with
pancreatitis by
promoting inflammation...
- agonists. In 2005, the U.S. Food and Drug
Administration approved the drug
exenatide (marketed as Byetta) for the
management of type 2 diabetes. It is a synthetic...
- the risk of thrombosis. It is an
antagonist of
glycoprotein IIb/IIIa.
Exenatide is a 39-amino-acid
peptide that is a
synthetic version of exendin-4, a...
- with
liraglutide 1.8 mg
compared to
insulin glargine, 0.33% more than
exenatide 10 μg
twice daily,
sitagliptin and rosiglitazone. In a
randomized controlled...
- K+ATP GLP-1
receptor agonists Albiglutide‡ Danuglipron†
Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§
Semaglutide Taspoglutide† DPP-4...
-
through swallowing air as a habit.
Diabetes drugs such as
metformin and
exenatide can
cause burping,
especially at
higher doses. This
often resolves in...
